Compare TEX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEX | PCVX |
|---|---|---|
| Founded | 1933 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 6.1B |
| IPO Year | 1994 | 2020 |
| Metric | TEX | PCVX |
|---|---|---|
| Price | $59.71 | $55.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $71.00 | ★ $98.33 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-12-2026 | 05-27-2026 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.33 | N/A |
| Revenue | ★ $5,421,000,000.00 | N/A |
| Revenue This Year | $47.78 | N/A |
| Revenue Next Year | $7.13 | N/A |
| P/E Ratio | $17.88 | ★ N/A |
| Revenue Growth | ★ 5.73 | N/A |
| 52 Week Low | $31.53 | $28.09 |
| 52 Week High | $71.50 | $76.61 |
| Indicator | TEX | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 39.30 | 45.44 |
| Support Level | $58.60 | $42.30 |
| Resistance Level | $62.37 | $56.04 |
| Average True Range (ATR) | 2.47 | 2.72 |
| MACD | -1.13 | -0.86 |
| Stochastic Oscillator | 9.73 | 23.13 |
Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.